Sheaff Brock Investment Advisors’s Sensus Healthcare SRTS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
Sell
-40,100
Closed -$152K 514
2024
Q1
$152K Sell
40,100
-2,500
-6% -$9.06K 0.01% 459
2023
Q4
$101K Hold
42,600
0.01% 452
2023
Q3
$118K Hold
42,600
0.01% 423
2023
Q2
$134K Buy
42,600
+2,200
+5% +$7.95K 0.01% 444
2023
Q1
$210K Buy
40,400
+1,400
+4% +$10.1K 0.02% 422
2022
Q4
$289K Buy
39,000
+18,000
+86% +$162K 0.03% 346
2022
Q3
$263K Sell
21,000
-13,264
-39% -$158K 0.03% 359
2022
Q2
$263K Buy
34,264
+9,000
+36% +$75.6K 0.02% 370
2022
Q1
$255K Buy
25,264
+3,550
+16% +$32.4K 0.02% 411
2021
Q4
$157K Sell
21,714
-5,000
-19% -$27.4K 0.01% 507
2021
Q3
$96K Buy
26,714
+10,000
+60% +$36.6K 0.01% 533
2021
Q2
$64K Hold
16,714
﹤0.01% 517
2021
Q1
$64K Sell
16,714
-4,286
-20% -$17.6K 0.01% 494
2020
Q4
$81K Hold
21,000
0.01% 469
2020
Q3
$53K Buy
21,000
+9,499
+83% +$26.8K ﹤0.01% 445
2020
Q2
$35K Buy
+11,501
New +$30K ﹤0.01% 445

Other funds holding SRTS

Sheaff Brock Investment Advisors's SRTS Position: Q2 2024 in Review

Sheaff Brock Investment Advisors sold out of Sensus Healthcare (SRTS) in Q2 2024, closing a stake of 40,100 shares — an estimated $152K sold.

Sheaff Brock Investment Advisors first reported a position in SRTS in Q2 2020 and held it in 16 quarters. The position peaked at $289K in Q4 2022. 47 funds tracked by Wall St. Rank hold SRTS as of Q2 2024.

  • Sheaff Brock Investment Advisors reported no remaining Sensus Healthcare position as of Q2 2024 after selling out during the quarter.
  • Sheaff Brock Investment Advisors sold 40,100 Sensus Healthcare shares in Q2 2024, an estimated $152K.
  • Sheaff Brock Investment Advisors first reported a position in Sensus Healthcare in Q2 2020 and held it in 16 quarters.
  • Sheaff Brock Investment Advisors's Sensus Healthcare position peaked at $289K in Q4 2022.
  • 47 funds tracked by Wall St. Rank held Sensus Healthcare as of Q2 2024.

Based on Sheaff Brock Investment Advisors's 13F filing for Q2 2024, filed 30 Jul 2024.